Your browser doesn't support javascript.
loading
Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
Prasad, Pragati V; Steele, Molly K; Reed, Carrie; Meyers, Lauren Ancel; Du, Zhanwei; Pasco, Remy; Alfaro-Murillo, Jorge A; Lewis, Bryan; Venkatramanan, Srinivasan; Schlitt, James; Chen, Jiangzhuo; Orr, Mark; Wilson, Mandy L; Eubank, Stephen; Wang, Lijing; Chinazzi, Matteo; Pastore Y Piontti, Ana; Davis, Jessica T; Halloran, M Elizabeth; Longini, Ira; Vespignani, Alessandro; Pei, Sen; Galanti, Marta; Kandula, Sasikiran; Shaman, Jeffrey; Haw, David J; Arinaminpathy, Nimalan; Biggerstaff, Matthew.
  • Prasad PV; Applied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.
  • Steele MK; Applied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.
  • Reed C; Applied Research and Modeling Team, Influenza Division, United States Centers for Disease Control and Prevention, Atlanta, GA 30333.
  • Meyers LA; Section of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.
  • Du Z; Section of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.
  • Pasco R; Section of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712.
  • Alfaro-Murillo JA; Department of Biostatistics & Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06510.
  • Lewis B; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Venkatramanan S; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Schlitt J; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Chen J; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Orr M; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Wilson ML; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Eubank S; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Wang L; Public Health Sciences, University of Virginia, Charlottesville, VA 22903.
  • Chinazzi M; Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA 22911.
  • Pastore Y Piontti A; Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
  • Davis JT; Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
  • Halloran ME; Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
  • Longini I; Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
  • Vespignani A; Department of Biostatistics, University of Washington, Seattle, WA 98195.
  • Pei S; Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32603.
  • Galanti M; Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA 02115.
  • Kandula S; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.
  • Shaman J; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.
  • Haw DJ; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.
  • Arinaminpathy N; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032.
  • Biggerstaff M; Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2AZ, United Kingdom.
Proc Natl Acad Sci U S A ; 120(28): e2300590120, 2023 07 11.
Article en En | MEDLINE | ID: mdl-37399393
When an influenza pandemic emerges, temporary school closures and antiviral treatment may slow virus spread, reduce the overall disease burden, and provide time for vaccine development, distribution, and administration while keeping a larger portion of the general population infection free. The impact of such measures will depend on the transmissibility and severity of the virus and the timing and extent of their implementation. To provide robust assessments of layered pandemic intervention strategies, the Centers for Disease Control and Prevention (CDC) funded a network of academic groups to build a framework for the development and comparison of multiple pandemic influenza models. Research teams from Columbia University, Imperial College London/Princeton University, Northeastern University, the University of Texas at Austin/Yale University, and the University of Virginia independently modeled three prescribed sets of pandemic influenza scenarios developed collaboratively by the CDC and network members. Results provided by the groups were aggregated into a mean-based ensemble. The ensemble and most component models agreed on the ranking of the most and least effective intervention strategies by impact but not on the magnitude of those impacts. In the scenarios evaluated, vaccination alone, due to the time needed for development, approval, and deployment, would not be expected to substantially reduce the numbers of illnesses, hospitalizations, and deaths that would occur. Only strategies that included early implementation of school closure were found to substantially mitigate early spread and allow time for vaccines to be developed and administered, especially under a highly transmissible pandemic scenario.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article